Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

Table 1

Comparison of baseline data between the two groups (%)).

Indicators	Control group ()	Study group ()
Gender			0.040	0.841
Male	24 (48.00)	23 (46.00)
Female	26 (52.00)	27 (54.00)
Average age (years)			0.266	0.791
Drinker at diagnosis	13 (26.00)	12 (24.00)	0.073	0.787
Smoker at diagnosis	16 (32.00)	14 (28.00)	0.191	0.663
Education level
University	18 (36.00)	20 (40.00)	0.170	0.680
High school	26 (52.00)	25 (50.00)	0.040	0.841
Elementary school	6 (12.00)	5 (10.00)	0.102	0.749
Family history of esophageal cancer
Yes	12 (24.00)	11 (22.00)	0.057	0.812
No	38 (76.00)	39 (78.00)